ID   BI2L1_HUMAN             Reviewed;         511 AA.
AC   Q9UHR4; A4D268; Q75L21; Q75L22; Q96CV4; Q9H5F5; Q9Y2M8;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   18-JUN-2025, entry version 201.
DE   RecName: Full=BAR/IMD domain-containing adapter protein 2-like 1 {ECO:0000312|HGNC:HGNC:21649};
DE   AltName: Full=Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1;
DE            Short=BAI1-associated protein 2-like protein 1;
DE   AltName: Full=Insulin receptor tyrosine kinase substrate;
GN   Name=BAIAP2L1; Synonyms=IRTKS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Adrenal gland;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H., Gu B.-W.,
RA   Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J., Xu S.-H., Gu J.,
RA   Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M., Huang G.-Y., Chen Z.,
RA   Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal axis
RT   and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 317-511.
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-261, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   FUNCTION, INTERACTION WITH RAC1 AND F-ACTIN, PHOSPHORYLATION, AND
RP   MUTAGENESIS OF LYS-141; LYS-142; ARG-145; LYS-146 AND 488-GLY--ARG-511.
RX   PubMed=17430976; DOI=10.1242/jcs.001776;
RA   Millard T.H., Dawson J., Machesky L.M.;
RT   "Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with
RT   distinct filament bundling properties.";
RL   J. Cell Sci. 120:1663-1672(2007).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-248; THR-257; SER-261;
RP   SER-281; SER-331 AND THR-412, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [13]
RP   FUNCTION, INTERACTION WITH E.COLI EFFECTOR PROTEIN ESPF(U), IDENTIFICATION
RP   IN A COMPLEX WITH WASL AND E.COLI EFFECTOR PROTEIN ESPF(U), INTERACTION
RP   WITH E.COLI INTIMIN RECEPTOR TIR, AND SUBCELLULAR LOCATION.
RX   PubMed=19366662; DOI=10.1073/pnas.0809131106;
RA   Vingadassalom D., Kazlauskas A., Skehan B., Cheng H.C., Magoun L.,
RA   Robbins D., Rosen M.K., Saksela K., Leong J.M.;
RT   "Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin
RT   assembly effectors Tir and EspF(U) during pedestal formation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:6754-6759(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-248; THR-257; SER-261 AND
RP   THR-412, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-257; SER-261; SER-281;
RP   SER-331 AND SER-354, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-331; SER-414 AND SER-420, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   STRUCTURE BY NMR OF 339-402 IN COMPLEX WITH E.COLI EFFECTOR PROTEIN
RP   ESPF(U), AND SUBUNIT.
RX   PubMed=21098279; DOI=10.1073/pnas.1010243107;
RA   Aitio O., Hellman M., Kazlauskas A., Vingadassalom D.F., Leong J.M.,
RA   Saksela K., Permi P.;
RT   "Recognition of tandem PxxP motifs as a unique Src homology 3-binding mode
RT   triggers pathogen-driven actin assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:21743-21748(2010).
RN   [19]
RP   STRUCTURE BY NMR OF 339-402 IN COMPLEX WITH WASL AND E.COLI ESPF(U),
RP   FUNCTION, AND IDENTIFICATION IN A COMPLEX WITH WASL AND E.COLI ESPF(U).
RX   PubMed=22921828; DOI=10.1016/j.str.2012.07.015;
RA   Aitio O., Hellman M., Skehan B., Kesti T., Leong J.M., Saksela K.,
RA   Permi P.;
RT   "Enterohaemorrhagic Escherichia coli exploits a tryptophan switch to hijack
RT   host f-actin assembly.";
RL   Structure 20:1692-1703(2012).
CC   -!- FUNCTION: May function as adapter protein. Involved in the formation of
CC       clusters of actin bundles. Plays a role in the reorganization of the
CC       actin cytoskeleton in response to bacterial infection.
CC       {ECO:0000269|PubMed:17430976, ECO:0000269|PubMed:19366662,
CC       ECO:0000269|PubMed:22921828}.
CC   -!- SUBUNIT: Interacts with RAC1. Binds to F-actin. Interacts with FASLG.
CC       Interacts (via SH3 domain) with E.coli effector protein EspF(U) (via
CC       PXXP motifs). Identified in a complex containing at least WASL,
CC       BAIAP2L1 and E.coli EspF(U). Interacts with E.coli intimin receptor
CC       Tir. {ECO:0000269|PubMed:17430976, ECO:0000269|PubMed:19366662,
CC       ECO:0000269|PubMed:19807924, ECO:0000269|PubMed:21098279,
CC       ECO:0000269|PubMed:22921828}.
CC   -!- INTERACTION:
CC       Q9UHR4; O95817: BAG3; NbExp=3; IntAct=EBI-2483278, EBI-747185;
CC       Q9UHR4; Q9UQB8: BAIAP2; NbExp=5; IntAct=EBI-2483278, EBI-525456;
CC       Q9UHR4; Q9UQB8-6: BAIAP2; NbExp=3; IntAct=EBI-2483278, EBI-9092016;
CC       Q9UHR4; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-2483278, EBI-3867333;
CC       Q9UHR4; Q12929: EPS8; NbExp=4; IntAct=EBI-2483278, EBI-375576;
CC       Q9UHR4; O43813: LANCL1; NbExp=3; IntAct=EBI-2483278, EBI-3046631;
CC       Q9UHR4; P0DJ88: espF(U); Xeno; NbExp=9; IntAct=EBI-2483278, EBI-10039462;
CC       Q9UHR4; Q7DB77: tir; Xeno; NbExp=3; IntAct=EBI-2483278, EBI-6480811;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:19366662}. Note=Recruited to actin pedestals that
CC       are formed upon infection by bacteria at bacterial attachment sites.
CC   -!- DOMAIN: The IMD domain is predicted to have a helical structure. It may
CC       induce actin bundling and filopodia formation (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine in response to insulin.
CC       {ECO:0000269|PubMed:17430976}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD20937.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAS07549.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB15671.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF119666; AAF17223.2; -; mRNA.
DR   EMBL; AC004841; AAD20937.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC093169; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093799; AAS07549.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC093799; AAS07550.1; -; Genomic_DNA.
DR   EMBL; CH236956; EAL23890.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76706.1; -; Genomic_DNA.
DR   EMBL; BC013888; AAH13888.1; -; mRNA.
DR   EMBL; AK027142; BAB15671.1; ALT_INIT; mRNA.
DR   CCDS; CCDS34687.1; -.
DR   RefSeq; NP_061330.2; NM_018842.4.
DR   PDB; 2KXC; NMR; -; A=339-402.
DR   PDB; 2LNH; NMR; -; B=339-402.
DR   PDBsum; 2KXC; -.
DR   PDBsum; 2LNH; -.
DR   AlphaFoldDB; Q9UHR4; -.
DR   BMRB; Q9UHR4; -.
DR   SMR; Q9UHR4; -.
DR   BioGRID; 121017; 143.
DR   DIP; DIP-53820N; -.
DR   FunCoup; Q9UHR4; 868.
DR   IntAct; Q9UHR4; 83.
DR   MINT; Q9UHR4; -.
DR   STRING; 9606.ENSP00000005260; -.
DR   GlyGen; Q9UHR4; 5 sites, 2 N-linked glycans (2 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UHR4; -.
DR   MetOSite; Q9UHR4; -.
DR   PhosphoSitePlus; Q9UHR4; -.
DR   SwissPalm; Q9UHR4; -.
DR   BioMuta; BAIAP2L1; -.
DR   DMDM; 74735022; -.
DR   jPOST; Q9UHR4; -.
DR   MassIVE; Q9UHR4; -.
DR   PaxDb; 9606-ENSP00000005260; -.
DR   PeptideAtlas; Q9UHR4; -.
DR   ProteomicsDB; 84402; -.
DR   Pumba; Q9UHR4; -.
DR   Antibodypedia; 16001; 207 antibodies from 31 providers.
DR   DNASU; 55971; -.
DR   Ensembl; ENST00000005260.9; ENSP00000005260.8; ENSG00000006453.14.
DR   GeneID; 55971; -.
DR   KEGG; hsa:55971; -.
DR   MANE-Select; ENST00000005260.9; ENSP00000005260.8; NM_018842.5; NP_061330.2.
DR   UCSC; uc003upj.4; human.
DR   AGR; HGNC:21649; -.
DR   CTD; 55971; -.
DR   DisGeNET; 55971; -.
DR   GeneCards; BAIAP2L1; -.
DR   HGNC; HGNC:21649; BAIAP2L1.
DR   HPA; ENSG00000006453; Tissue enhanced (stomach).
DR   MIM; 611877; gene.
DR   OpenTargets; ENSG00000006453; -.
DR   VEuPathDB; HostDB:ENSG00000006453; -.
DR   eggNOG; ENOG502QQC6; Eukaryota.
DR   GeneTree; ENSGT00940000153560; -.
DR   HOGENOM; CLU_025877_0_1_1; -.
DR   InParanoid; Q9UHR4; -.
DR   OMA; YQAEHRS; -.
DR   OrthoDB; 3800937at2759; -.
DR   PAN-GO; Q9UHR4; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9UHR4; -.
DR   PathwayCommons; Q9UHR4; -.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013404; RAC2 GTPase cycle.
DR   Reactome; R-HSA-9013423; RAC3 GTPase cycle.
DR   Reactome; R-HSA-9035034; RHOF GTPase cycle.
DR   SignaLink; Q9UHR4; -.
DR   SIGNOR; Q9UHR4; -.
DR   BioGRID-ORCS; 55971; 20 hits in 1164 CRISPR screens.
DR   ChiTaRS; BAIAP2L1; human.
DR   EvolutionaryTrace; Q9UHR4; -.
DR   GeneWiki; BAIAP2L1; -.
DR   GenomeRNAi; 55971; -.
DR   Pharos; Q9UHR4; Tbio.
DR   PRO; PR:Q9UHR4; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9UHR4; protein.
DR   Bgee; ENSG00000006453; Expressed in pancreatic ductal cell and 182 other cell types or tissues.
DR   GO; GO:0005912; C:adherens junction; HDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0098641; F:cadherin binding involved in cell-cell adhesion; HDA:BHF-UCL.
DR   GO; GO:0070064; F:proline-rich region binding; IDA:UniProtKB.
DR   GO; GO:0051764; P:actin crosslink formation; IBA:GO_Central.
DR   GO; GO:0051017; P:actin filament bundle assembly; IBA:GO_Central.
DR   GO; GO:0007009; P:plasma membrane organization; IEA:InterPro.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IDA:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB.
DR   CDD; cd07645; I-BAR_IMD_BAIAP2L1; 1.
DR   CDD; cd11913; SH3_BAIAP2L1; 1.
DR   FunFam; 2.30.30.40:FF:000018; Brain-specific angiogenesis inhibitor 1-associated protein 2; 1.
DR   FunFam; 1.20.1270.60:FF:000043; Brain-specific angiogenesis inhibitor 1-associated protein 2-like 1; 1.
DR   Gene3D; 1.20.1270.60; Arfaptin homology (AH) domain/BAR domain; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   IDEAL; IID00331; -.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR030060; Baiap2l1_I-BAR_dom.
DR   InterPro; IPR013606; I-BAR_dom.
DR   InterPro; IPR027681; IRSp53/IRTKS/Pinkbar.
DR   InterPro; IPR035592; IRTKS_SH3.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR14206; BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1-ASSOCIATED PROTEIN 2; 1.
DR   PANTHER; PTHR14206:SF4; BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1-ASSOCIATED PROTEIN 2-LIKE PROTEIN 1; 1.
DR   Pfam; PF08397; IMD; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; BAR/IMD domain-like; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS51338; IMD; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   neXtProt; NX_Q9UHR4; -.
DR   PharmGKB; PA142672562; -.
DR   TreeFam; TF325648; -.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Phosphoprotein; Proteomics identification; Reference proteome; SH3 domain.
FT   CHAIN           1..511
FT                   /note="BAR/IMD domain-containing adapter protein 2-like 1"
FT                   /id="PRO_0000247854"
FT   DOMAIN          1..249
FT                   /note="IMD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00668"
FT   DOMAIN          339..402
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          302..328
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          451..511
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          483..511
FT                   /note="Binds F-actin"
FT   COILED          115..154
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        303..328
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         248
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         257
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         261
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         331
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         354
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         412
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         414
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         420
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         422
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBJ3"
FT   VARIANT         460
FT                   /note="S -> T (in dbSNP:rs2269966)"
FT                   /id="VAR_033515"
FT   MUTAGEN         141
FT                   /note="K->E: Loss ability to induce the formation of actin
FT                   clusters; when associated with K-142; R-145 and K-146."
FT                   /evidence="ECO:0000269|PubMed:17430976"
FT   MUTAGEN         142
FT                   /note="K->E: Loss ability to induce the formation of actin
FT                   clusters; when associated with K-141; R-145 and K-146."
FT                   /evidence="ECO:0000269|PubMed:17430976"
FT   MUTAGEN         145
FT                   /note="R->E: Loss ability to induce the formation of actin
FT                   clusters; when associated with K-141; K-142 and K-146."
FT                   /evidence="ECO:0000269|PubMed:17430976"
FT   MUTAGEN         146
FT                   /note="K->E: Loss ability to induce the formation of actin
FT                   clusters; when associated with K-141; K-142 and R-145."
FT                   /evidence="ECO:0000269|PubMed:17430976"
FT   MUTAGEN         488..511
FT                   /note="Missing: Loss ability to induce the formation of
FT                   actin clusters; induce the formation of long filopodia."
FT                   /evidence="ECO:0000269|PubMed:17430976"
FT   CONFLICT        456
FT                   /note="A -> V (in Ref. 6; BAB15671)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        460
FT                   /note="S -> F (in Ref. 6; BAB15671)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        464
FT                   /note="A -> V (in Ref. 6; BAB15671)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        466
FT                   /note="A -> V (in Ref. 6; BAB15671)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        467
FT                   /note="S -> F (in Ref. 6; BAB15671)"
FT                   /evidence="ECO:0000305"
FT   STRAND          343..348
FT                   /evidence="ECO:0007829|PDB:2KXC"
FT   STRAND          356..358
FT                   /evidence="ECO:0007829|PDB:2KXC"
FT   STRAND          366..373
FT                   /evidence="ECO:0007829|PDB:2KXC"
FT   STRAND          378..386
FT                   /evidence="ECO:0007829|PDB:2KXC"
FT   STRAND          389..393
FT                   /evidence="ECO:0007829|PDB:2KXC"
FT   HELIX           394..396
FT                   /evidence="ECO:0007829|PDB:2KXC"
FT   STRAND          397..400
FT                   /evidence="ECO:0007829|PDB:2KXC"
SQ   SEQUENCE   511 AA;  56883 MW;  C2304C4444B02F02 CRC64;
     MSRGPEEVNR LTESTYRNVM EQFNPGLRNL INLGKNYEKA VNAMILAGKA YYDGVAKIGE
     IATGSPVSTE LGHVLIEISS THKKLNESLD ENFKKFHKEI IHELEKKIEL DVKYMNATLK
     RYQTEHKNKL ESLEKSQAEL KKIRRKSQGS RNALKYEHKE IEYVETVTSR QSEIQKFIAD
     GCKEALLEEK RRFCFLVDKH CGFANHIHYY HLQSAELLNS KLPRWQETCV DAIKVPEKIM
     NMIEEIKTPA STPVSGTPQA SPMIERSNVV RKDYDTLSKC SPKMPPAPSG RAYTSPLIDM
     FNNPATAAPN SQRVNNSTGT SEDPSLQRSV SVATGLNMMK KQKVKTIFPH TAGSNKTLLS
     FAQGDVITLL IPEEKDGWLY GEHDVSKARG WFPSSYTKLL EENETEAVTV PTPSPTPVRS
     ISTVNLSENS SVVIPPPDYL ECLSMGAAAD RRADSARTTS TFKAPASKPE TAAPNDANGT
     AKPPFLSGEN PFATVKLRPT VTNDRSAPII R
//
